Guarding the Bcl-2 army.
Schmidt-Mende
Jan
J
Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Stockholm, Sweden.
Zhivotovsky
Boris
B
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D017209:Apoptosis; D003561:Cytarabine / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm; D018922:HL-60 Cells; D006801:Humans; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis* / Q000494:pharmacology*; D015854:Up-Regulation; D051020:bcl-X Protein
D000964:Antimetabolites, Antineoplastic; C494811:BCL2L1 protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D051020:bcl-X Protein; D003561:Cytarabine